AzTrials
AzTrials

Cardiac DiseaseTEENCT06164171

Transesophageal Echocardiography (TEE) and Simulation : a Preferred Learning Path

An observational study of Cardiac Disease, run by University Hospital, Strasbourg, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Transesophageal echocardiography (TEE) has gradually become the technique of choice for continuous functional examination of the heart despite the significant training required for its interpretation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Disease
How many people
26 participants
Where
1 siteFrance
Study dates
9 Jun 2020to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: 1st or 2nd year DESAR interns who participated in the continuing education program

Who may be able to join

  • 1st or 2nd year DESAR interns who participated in the continuing education program
  • Interns who agreed to participate in the professional practice evaluation study

Who cannot join

  • Interns who did not participate in the training
  • Residents who do not agree to take the final test

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Service de Réanimation Chirurgicale - CHU de Strasbourg - France

    Strasbourg, 67091

    Walid OULEHRI, MD, 33 3 69 55 12 71, walid.oulehri@chru-strasbourg.fr

    Walid OULEHRI, MD

    Recruiting

Other trials in France

About this study

Transesophageal echocardiography (TEE) has gradually become the technique of choice for continuous functional examination of the heart despite the significant training required for its interpretation. It has proven to be the safest, fastest, and most reliable technique for diagnosing most intra- and postoperative hemodynamic problems. Indeed, the transesophageal route is particularly well adapted to the situation of intubated patients, whether in the operating room, in the outpatient department or in intensive care. It offers images that are easier to obtain and of better quality than the transthoracic route; it can be performed without interfering with surgical activity or resuscitation. However, TEE training is often poor during the DES training in anesthesia and resuscitation, reserved for the few interns who will learn in a specific department where TEE is used on a daily basis.

Thus, simulation is a logical and recognized means by which technical aspects, mechanisms involved in the understanding of a situation, reasoning and decision making can be analyzed and improved.

Read more

The RFE SFAR 2019 recommendations suggest the use of simulation for the learning of technical gestures in initial training in order to improve their acquisition.

This study is therefore part of a technical and diagnostic improvement of a practice, which appears to be essential in several fields in anesthesia and intensive care, for a technique still not sufficiently acquired by many future practitioners.

Conditions
Cardiac Disease
Keywords
Cardiac disease, Transesophageal echocardiography, TEE, High definition simulator
Medical subject headings
Heart Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ability of a population of medical students to perform a TEE thanks to the contribution of simulation to their learning compared to a population of interns not trained on a high definition simulator Time in seconds required to make the 11 cuts

    Measured: 1 hour after operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2023
  2. Study start9 Jun 2020
  3. Primary completionDec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
26 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06164171
Sponsor's protocol ID
7646
Acronym
TEE
Status last verified
Dec 2023
First submitted
8 Nov 2022
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Disease, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Walid OULEHRI, MD (33 3 69 55 12 71, walid.oulehri@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ability of a population of medical students to perform a TEE thanks to the contribution of simulation to their learning compared to a population of interns not trained on a high definition simulator Time in seconds required to make the 11 cuts (time frame: 1 hour after operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in